Praxis Precision Medicines, Inc. PRAX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s PP&E (net)?
- Praxis Precision Medicines, Inc. (PRAX) reported PP&E (net) of $170K in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s PP&E (net) changed year-over-year?
- Praxis Precision Medicines, Inc.'s PP&E (net) decreased by 31.2% year-over-year, from $247K to $170K.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s PP&E (net) has grown at a 12.4% compound annual growth rate (CAGR), from $82K to $147K.
- What does PP&E (net) mean?
- The value of physical assets like equipment and facilities after accounting for wear and tear.
- How do you interpret PP&E (net)?
- An increase indicates capital investment in infrastructure, while a decrease reflects depreciation or the disposal of assets.
- How does PP&E (net) compare across companies?
- Biotech firms typically have lower levels of property and equipment compared to manufacturing firms, as they often outsource production.